Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Annals of the Rheumatic Diseases
|
January 21, 2014
Zoledronate for prevention of bone erosion in tophaceous gout: a randomised, double-blind, placebo-controlled trial
Nicola Dalbeth, Opetaia Aati, Gregory D Gamble, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
May 30, 2023
Assessing Oral Epithelial Dysplasia Risk for Transformation to Cancer: Comparison Between Histologic Grading Systems Versus S100A7 Immunohistochemical Signature-based Grading
Mark Roger Darling, Jason T K Hwang, Benjamin J Dickson, et al.
The Journal of Rheumatology
|
January 17, 2016
Path Analysis Identifies Receptor Activator of Nuclear Factor-κB Ligand, Osteoprotegerin, and Sclerostin as Potential Mediators of the Tophus-bone Erosion Relationship in Gout
Ashika Chhana, Opetaia Aati, Gregory D Gamble, et al.
BMC Nephrology
|
July 17, 2013
Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass
Joanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
BMC Nephrology
|
August 8, 2015
Update: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass
Joanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
BMC Nephrology
|
July 23, 2014
Rationale and design of the Myocardial Microinjury and Cardiac Remodeling Extension Study in the Sodium Lowering in Dialysate trial (Mac-SoLID study)
Joanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Annals of the Rheumatic Diseases
|
January 21, 2014
Zoledronate for prevention of bone erosion in tophaceous gout: a randomised, double-blind, placebo-controlled trial
Nicola Dalbeth, Opetaia Aati, Gregory D Gamble, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
May 30, 2023
Assessing Oral Epithelial Dysplasia Risk for Transformation to Cancer: Comparison Between Histologic Grading Systems Versus S100A7 Immunohistochemical Signature-based Grading
Mark Roger Darling, Jason T K Hwang, Benjamin J Dickson, et al.
The Journal of Rheumatology
|
January 17, 2016
Path Analysis Identifies Receptor Activator of Nuclear Factor-κB Ligand, Osteoprotegerin, and Sclerostin as Potential Mediators of the Tophus-bone Erosion Relationship in Gout
Ashika Chhana, Opetaia Aati, Gregory D Gamble, et al.
BMC Nephrology
|
July 17, 2013
Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass
Joanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
BMC Nephrology
|
August 8, 2015
Update: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass
Joanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
BMC Nephrology
|
July 23, 2014
Rationale and design of the Myocardial Microinjury and Cardiac Remodeling Extension Study in the Sodium Lowering in Dialysate trial (Mac-SoLID study)
Joanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
Page
of 3